CNS Pharmaceuticals (CNSP) Short Interest Ratio & Short Volume $0.10 -0.01 (-10.30%) (As of 12:19 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends CNS Pharmaceuticals Short Interest DataCNS Pharmaceuticals (CNSP) has a short interest of 1.11 million shares. This marks a 63.48% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 5.33 million shares to cover all short positions.Current Short Interest1,110,000 sharesPrevious Short Interest679,000 sharesChange Vs. Previous Month+63.48%Dollar Volume Sold Short$137,862.00Short Interest Ratio0.1 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares33,450,000 sharesPercentage of Shares Shorted3.32%Today's Trading Volume2,855,645 sharesAverage Trading Volume5,334,011 sharesToday's Volume Vs. Average54% Short Selling CNS Pharmaceuticals? Sign up to receive the latest short interest report for CNS Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCNSP Short Interest Over TimeCNSP Days to Cover Over TimeCNSP Percentage of Float Shorted Over Time Ad Weiss RatingsThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.”Click here to find out more about what could be Trump and JD Vance’s favorite coin. CNS Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/20241,110,000 shares $137,862.00 +63.5%N/A0.1 $0.12 9/30/2024679,000 shares $88,609.50 +86.2%N/A0.1 $0.13 9/15/2024364,600 shares $54,033.72 +80.1%N/A0.1 $0.15 8/31/2024202,500 shares $31,833.00 +87.7%N/A0 $0.16 8/15/2024107,900 shares $15,213.90 -90.3%N/A0 $0.14 7/31/20241,110,000 shares $351,648.00 +314.3%40.1%0.3 $0.32 Get the Latest News and Ratings for CNSP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CNS Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/15/2024267,900 shares $316,122.00 +229.9%9.7%0.2 $1.18 6/30/202481,200 shares $128,296.00 +29.7%5.8%0.1 $1.58 6/15/202462,600 shares $174,654.00 +1,465.0%27.3%0.2 $2.79 5/31/20244,000 shares $43,240.00 -93.6%1.8%0.2 $10.81 5/15/202462,500 shares $12,006.25 +100.3%0.6%0.2 $0.19 4/30/202431,200 shares $6,552.00 +35.1%0.3%0.1 $0.21 4/15/202423,100 shares $5,530.14 -53.8%0.2%0.1 $0.24 3/31/202450,000 shares $18,100.00 -51.8%0.5%0.1 $0.36 3/15/2024103,800 shares $36,983.94 +91.5%1.3%0.3 $0.36 2/29/202454,200 shares $15,067.60 -47.2%0.7%0.1 $0.28 2/15/2024102,600 shares $29,035.80 -87.2%1.3%0.3 $0.28 1/31/2024802,400 shares $198,995.20 +317.1%10.2%2.6 $0.25 1/15/2024192,400 shares $179,894.00 -10.8%3.1%1.6 $0.94 12/31/2023215,700 shares $273,939.00 +298.0%3.5%2.1 $1.27 12/15/202354,200 shares $93,766.00 +30.6%0.9%0.5 $1.73 11/30/202341,500 shares $86,320.00 +75.1%0.8%0.6 $2.08 11/15/202323,700 shares $45,504.00 -50.3%0.5%0.3 $1.92 10/31/202347,700 shares $98,739.00 -36.6%1.2%0.3 $2.07 10/15/202375,200 shares $101,520.00 +22.7%1.8%0.5 $1.35 9/30/202361,300 shares $69,882.00 -8.5%1.5%0.5 $1.14 9/15/202367,000 shares $100,500.00 -45.2%1.6%0.4 $1.50 8/31/2023122,300 shares $209,133.00 +69.6%3.0%0.6 $1.71 8/15/202372,100 shares $123,291.00 -3.1%1.8%0.2 $1.71 7/31/202374,400 shares $168,144.00 +11.4%1.8%0.2 $2.26 7/15/202366,800 shares $142,952.00 -70.0%1.6%0 $2.14 6/30/2023222,600 shares $496,398.00 +7.2%5.5%0.1 $2.23 6/15/2023207,600 shares $448,416.00 -9.4%5.1%0.1 $2.16 5/31/2023229,100 shares $421,544.00 +91.6%5.7%0.1 $1.84 5/15/2023119,600 shares $166,244.00 -44.6%3.0%0 $1.39 4/30/2023215,800 shares $325,858.00 +306.4%10.0%0.1 $1.51 4/15/202353,100 shares $124,785.00 +410.6%3.1%0 $2.35 3/31/202310,400 shares $10,400.00 -57.6%0.6%0 $1.00 3/15/202324,500 shares $30,380.00 +49.4%2.3%0.6 $1.24 2/28/202316,400 shares $30,340.00 +62.4%1.6%0.4 $1.85The centerpiece of Trump’s crypto’s masterplan … (Ad)Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.”Click here to find out more about what could be Trump and JD Vance’s favorite coin. 2/15/202310,100 shares $17,372.00 +206.1%1.0%0.3 $1.72 1/31/20233,300 shares $7,293.00 +153.9%0.3%0.1 $2.21 1/15/20231,300 shares $3,120.00 -63.9%0.1%0.1 $2.40 12/30/20223,600 shares $8,640.00 -65.4%0.3%0.2 $2.40 12/15/202210,400 shares $26,520.00 -2.8%0.8%0.6 $2.55 11/30/202210,700 shares $32,421.00 -88.5%1.1%0.7 $3.03 11/15/202293,200 shares $17,717.32 +24.4%N/A0.5 $0.19 10/31/202274,900 shares $11,984.00 +21.2%N/A0.4 $0.16 10/15/202261,800 shares $12,656.64 -65.7%N/A0.3 $0.20 9/30/2022180,000 shares $32,220.00 -14.6%N/A0.7 $0.18 9/15/2022210,800 shares $51,856.80 +15.0%N/A0.4 $0.25 8/31/2022183,300 shares $44,798.52 -1.6%N/A0.3 $0.24 8/15/2022186,200 shares $48,207.18 +17.7%N/A0.3 $0.26 7/31/2022158,200 shares $34,756.54 +870.6%N/A0.3 $0.22 7/15/202216,300 shares $4,401.00 -95.0%N/A0 $0.27 6/30/2022325,800 shares $91,224.00 +15.4%N/A0.4 $0.28 6/15/2022282,400 shares $77,010.48 -46.6%N/A0.3 $0.27 5/31/2022528,500 shares $160,241.20 +80.6%N/A0.6 $0.30 5/15/2022292,600 shares $84,854.00 -19.7%N/A0.2 $0.29 4/30/2022364,500 shares $123,201.00 -9.5%N/A0.2 $0.34 4/15/2022402,800 shares $157,092.00 +1,154.8%N/A0.3 $0.39 3/31/202232,100 shares $10,946.10 -89.0%N/A0 $0.34 3/15/2022291,000 shares $93,120.00 -46.3%1.6%0.2 $0.32 2/28/2022541,900 shares $211,341.00 +41.6%3.1%0.4 $0.39 2/15/2022382,700 shares $133,945.00 -69.9%2.2%0.5 $0.35 1/31/20221,270,000 shares $763,270.00 +8.6%7.2%1.7 $0.60 1/15/20221,170,000 shares $895,050.00 +353.7%6.6%1.6 $0.77 12/31/2021257,900 shares $181,148.96 +8.8%1.5%0.4 $0.70 12/15/2021237,000 shares $218,182.20 -21.5%1.4%1.1 $0.92 11/30/2021301,800 shares $338,016.00 +16.1%1.7%1.4 $1.12 11/15/2021260,000 shares $293,800.00 -19.7%1.5%1.3 $1.13 10/29/2021323,900 shares $446,982.00 -10.8%1.9%2.2 $1.38 10/15/2021363,200 shares $533,904.00 -2.6%2.1%2.7 $1.47 9/30/2021373,000 shares $555,770.00 -16.9%2.2%2.1 $1.49 9/15/2021448,700 shares $695,485.00 +6.9%2.6%0.9 $1.55 8/31/2021419,600 shares $713,320.00 0.0%2.6%0.8 $1.70 8/13/2021419,700 shares $700,899.00 -3.9%2.6%0.8 $1.67 7/30/2021436,900 shares $751,468.00 -28.0%2.9%0.9 $1.72 7/15/2021607,000 shares $1.09 million +57.5%4.0%1.2 $1.80 6/30/2021385,400 shares $755,384.00 +30.4%2.6%0.8 $1.96 6/15/2021295,600 shares $588,244.00 +1.2%2.0%1.9 $1.99 5/28/2021292,100 shares $540,385.00 -12.7%1.9%1.3 $1.85 5/14/2021334,400 shares $571,824.00 +11.1%2.2%1.2 $1.71 4/30/2021300,900 shares $616,845.00 -4.2%2.0%0.5 $2.05 4/15/2021314,100 shares $669,033.00 -17.0%2.1%0.2 $2.13 3/31/2021378,400 shares $877,888.00 -26.9%2.5%0.2 $2.32 3/15/2021517,400 shares $1.38 million -1.4%3.4%0.2 $2.67 2/26/2021524,900 shares $1.51 million +0.8%3.5%0.2 $2.88 2/12/2021520,600 shares $1.92 million +688.8%3.6%0.2 $3.68 1/29/202166,000 shares $119,460.00 -53.2%0.5%0 $1.81The centerpiece of Trump’s crypto’s masterplan … (Ad)Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.”Click here to find out more about what could be Trump and JD Vance’s favorite coin. 1/15/2021140,900 shares $264,892.00 +13.7%1.0%0.1 $1.88 12/31/2020123,900 shares $219,303.00 +89.7%0.9%0.1 $1.77 12/15/202065,300 shares $158,679.00 -4.3%0.9%0.1 $2.43 11/30/202068,200 shares $163,680.00 -15.0%1.0%1.4 $2.40 11/15/202080,200 shares $170,024.00 +6.5%1.2%1.1 $2.12 10/30/202075,300 shares $134,787.00 -1.3%1.2%0.8 $1.79 10/15/202076,300 shares $144,970.00 -10.7%1.2%0.8 $1.90 9/30/202085,400 shares $150,304.00 -5.6%1.3%0.8 $1.76 9/15/202090,500 shares $177,380.00 -25.6%1.4%0.9 $1.96 8/31/2020121,700 shares $261,655.00 +32.4%1.9%0.9 $2.15 8/14/202091,900 shares $162,663.00 -9.6%1.4%0.9 $1.77 7/31/2020101,600 shares $188,976.00 +19.0%1.6%1.4 $1.86 7/15/202085,400 shares $146,888.00 -15.1%1.3%1.2 $1.72 6/30/2020100,600 shares $215,284.00 -30.6%1.6%0.7 $2.14 6/15/2020144,900 shares $357,903.00 +45.6%2.2%1 $2.47 5/29/202099,500 shares $238,800.00 +22.4%1.5%0.8 $2.40 5/15/202081,300 shares $224,388.00 +4.9%1.3%0.5 $2.76 4/30/202077,500 shares $222,425.00 -29.7%1.2%0.5 $2.87 4/15/2020110,200 shares $360,354.00 +106.8%1.7%0.7 $3.27 3/31/202053,300 shares $148,707.00 -43.0%0.8%0.3 $2.79 3/13/202093,500 shares $312,290.00 +29.5%1.4%0.6 $3.34 2/28/202072,200 shares $173,280.00 +1.4%1.1%0.8 $2.40 2/14/202071,200 shares $250,624.00 -6.9%1.1%1 $3.52 1/31/202076,500 shares $289,935.00 -34.6%1.2%0.7 $3.79 1/15/2020117,000 shares $479,700.00 -19.1%1.8%0.9 $4.10 12/31/2019144,600 shares $636,240.00 No Change3.3%1.1 $4.40 CNSP Short Interest - Frequently Asked Questions What is CNS Pharmaceuticals' current short interest? Short interest is the volume of CNS Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of October 15th, investors have sold 1,110,000 shares of CNSP short. Learn More on CNS Pharmaceuticals' current short interest. Is CNS Pharmaceuticals' short interest increasing or decreasing? CNS Pharmaceuticals saw a increase in short interest during the month of October. As of October 15th, there was short interest totaling 1,110,000 shares, an increase of 63.5% from the previous total of 679,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does CNS Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to CNS Pharmaceuticals: Pulmatrix, Inc. (0.18%), Cumberland Pharmaceuticals Inc. (0.51%), TherapeuticsMD, Inc. (0.21%), Minerva Neurosciences, Inc. (0.13%), Sol-Gel Technologies Ltd. (2.31%), Synlogic, Inc. (0.76%), GeoVax Labs, Inc. (2.69%), HCW Biologics Inc. (0.13%), ImmunoPrecise Antibodies Ltd. (0.67%), Talphera, Inc. (0.21%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short CNS Pharmaceuticals stock? Short selling CNSP is an investing strategy that aims to generate trading profit from CNS Pharmaceuticals as its price is falling. CNSP shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against CNS Pharmaceuticals? A short squeeze for CNS Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CNSP, which in turn drives the price of the stock up even further. How often is CNS Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CNSP, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies Pulmatrix Short Interest Data Cumberland Pharmaceuticals Short Interest Data TherapeuticsMD Short Interest Data Minerva Neurosciences Short Interest Data Sol-Gel Technologies Short Interest Data Synlogic Short Interest Data GeoVax Labs Short Interest Data HCW Biologics Short Interest Data ImmunoPrecise Antibodies Short Interest Data Talphera Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CNSP) was last updated on 11/4/2024 by MarketBeat.com Staff From Our PartnersCRUSHED: How Biden's Replacement Will Devastate Your 401(k)!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a ...Golden Crest | Sponsored[Charles Payne Live Event] Click to Confirm Your RSVPThe Blueprint to Protect Your Portfolio Charles Payne reveals a strategy few investors know about Unstoppable Prosperity | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CNS Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CNS Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.